A company committed to science must also inspire the next generation of scientists. It’s the only way to build the pool of talent to one day discover and develop new medicines.
Novartis has established numerous fellowship, internship and exchange programs with universities and research institutions, helping build a foundation for sustaining research and medicine in developing countries and beyond.
Novartis International Biotechnology Leadership Camp
We also bring together selected top students from science and business universities from around the world through our annual Novartis International Biotechnology Leadership Camp (BioCamp).
Novartis Science Lab and Program at LINK Community School
Novartis works to inspire the next generation of innovators. The Novartis US Foundation sponsored the creation of the Novartis Science Lab and Program at LINK Community School, an independent middle school established to help provide an outstanding education for adolescents from economically disadvantaged families in Newark, New Jersey. Scientists and researchers from Novartis Group Companies mentor LINK students to help them prepare for high school and college science curricula.
Summer Research Fellowships
NIBR fellowships offer scientists across Africa the opportunity to conduct research on the NIBR campus alongside our scientists over a three-month period in Cambridge, Massachusetts. Since its inception the fellowship program has included scientists from sub-Saharan Africa including Kenya (Kenyatta University, Nairobi University and Egerton University), Ghana and Mali. For established scientists in developing countries, the fellowships open many opportunities, where they can carry on their own research, often in collaboration with their host labs.
Helping students to advance in science
Novartis scientists mentor middle school students from the Cambridgeport School near Boston, Massachusetts in the United States. Scientists and students meet and email throughout the school year focusing on science assignments that culminate with a science fair and graduation. The students are inquisitive and want to know how things work in everyday life. Their interactions with their Novartis mentors keep them excited about technology and scientific explanations of everyday phenomenon.
“In our neighborhood schools today are the scientists of tomorrow, but many find the field irrelevant,” says Mark Fishman, M.D., President of NIBR. “The impact of science on drug discovery means we must help to engage these students.”
Novartis also conducts educational workshops for scientists and educators from developing countries who are interested in the fundamental principles of drug discovery, preclinical research and clinical trial design. In 2012, workshops were held in Kenya, Ghana and Zimbabwe, and in 2013 workshops were offered in Nigeria and Ethiopia. In addition, Novartis offers workshops in clinical areas, for example cardiovascular trainings for physicians in Zambia.
Opportunities exist for Novartis scientists to expand their own personal and professional horizons by conducting research and teaching in local institutions, hospitals and universities in the developing world. Sabbaticals provide a vital link between scientists that share the goal of addressing the world’s most pressing medical challenges, a deeper understanding of the nature and impact of those challenges, and a keener insight into their solutions. Sabbaticals may be initiated by institutions in developing countries that may wish to bring in a Novartis scientist with expertise in a certain area, or Novartis scientists may initiate a request for an externship in different regions of the world.
Postdoctoral research fellowships are available for developing world students of science or medicine at the Novartis Institute for Tropical Diseases (NITD) in Singapore, focusing on neglected disease research, including tuberculosis, malaria and dengue fever. The students who join the program arrive mostly from Africa, bringing with them a desire to develop their knowledge in pharmacology, medicine, preclinical and early clinical research. All went back to their country of origin to carry on their research at their home institutions.